Table 2.
[18F]FDG PET/CT finding | Perfusion finding (SPECT or PET) | CMR findings | Final interpretation |
---|---|---|---|
No [18F]FDG uptake | Normal | No LGE | No CS (< 10%) |
Diffused [18F]FDG uptake (homogeneous) | Normal | No LGE | Uptake most likely due to suboptimal patient preparation |
Isolated lateral wall [18F]FDG uptake | Normal | No LGE | Uptake possibly related to a normal variant |
No [18F]FDG uptake | Small perfusion defect | One focal area of LGE (alternative diagnosis are most likely) | Possible CS (50–90%) |
Focal area of [18F]FDG uptake | Normal | ||
No [18F]FDG uptake | Multiple non-contiguous areas of perfusion defect | Typical LGE | Probable CS (50–90%) |
Focal or focal on diffused[18F]FDG uptake | Resting perfusion defect | ||
Focal area of [18F]FDG uptake + extracardiac findings | Normal | Typical LGE | Active cardiac sarcoidosis (> 90%) |
Focal on diffused[18F]FDG uptake | Perfusion defect | Typical LGE | Active inflammation with scar in the same location with either diffused inflammation or suboptimal preparation |
Focal area of [18F]FDG uptake in an area of normal perfusion | Perfusion defect | Typical LGE | Presence of both inactive scar and inflammation in different segments of the myocardium or inactive scar and false-positive physiological [18F]FDG uptake |
LGE late gadolinium enhancement